Antibiotic prophylaxis in breast cancer surgery (PAUS trial): randomised clinical double-blind parallel-group multicentre superiority trial.
Stallard S, Savioli F, McConnachie A, Norrie J, Dudman K, Morrow ES et al.
Br J Surg 2022; 109: 1224–1231.
In this study that included 871 procedures, a single dose of Amoxicillin-clavulanic acid did not reduce the risk of wound infection up to 30 days: 16.2 per cent versus 19.2 per cent in controls, P=0.25.
Comment: not beneficial even in higher risk subgroups – obese or Staph aureus carriers.
26 January 2023
Read paperAcademy
Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.
The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.
